BioNTech SE (BNTX)
103.40
-8.08
(-7.25%)
USD |
NASDAQ |
Nov 14, 16:00
102.20
-1.20
(-1.16%)
After-Hours: 20:00
BioNTech Enterprise Value: 8.336B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 8.336B |
| November 12, 2024 | 7.099B |
| November 11, 2024 | 7.676B |
| November 08, 2024 | 8.134B |
| November 07, 2024 | 7.473B |
| November 06, 2024 | 7.175B |
| November 05, 2024 | 8.213B |
| November 04, 2024 | 7.734B |
| November 01, 2024 | 8.336B |
| October 31, 2024 | 8.724B |
| October 30, 2024 | 8.926B |
| October 29, 2024 | 8.942B |
| October 28, 2024 | 8.763B |
| October 25, 2024 | 8.096B |
| October 24, 2024 | 8.396B |
| October 23, 2024 | 8.216B |
| October 22, 2024 | 8.192B |
| October 21, 2024 | 8.360B |
| October 18, 2024 | 8.405B |
| October 17, 2024 | 9.053B |
| October 16, 2024 | 9.837B |
| October 15, 2024 | 9.786B |
| October 14, 2024 | 10.41B |
| October 11, 2024 | 10.50B |
| October 10, 2024 | 9.988B |
| Date | Value |
|---|---|
| October 09, 2024 | 9.772B |
| October 08, 2024 | 10.45B |
| October 07, 2024 | 10.75B |
| October 04, 2024 | 11.02B |
| October 03, 2024 | 10.33B |
| October 02, 2024 | 10.14B |
| October 01, 2024 | 10.36B |
| September 30, 2024 | 10.08B |
| September 27, 2024 | 9.842B |
| September 26, 2024 | 9.704B |
| September 25, 2024 | 9.267B |
| September 24, 2024 | 9.902B |
| September 23, 2024 | 8.613B |
| September 20, 2024 | 8.430B |
| September 19, 2024 | 8.485B |
| September 18, 2024 | 9.224B |
| September 17, 2024 | 11.39B |
| September 16, 2024 | 11.09B |
| September 13, 2024 | 11.07B |
| September 12, 2024 | 6.699B |
| September 11, 2024 | 5.337B |
| September 10, 2024 | 5.660B |
| September 09, 2024 | 5.636B |
| September 06, 2024 | 3.118B |
| September 05, 2024 | 3.168B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
365.00M
Minimum
Aug 05 2024
107.68B
Maximum
Aug 09 2021
23.00B
Average
17.07B
Median
Enterprise Value Benchmarks
| Edap TMS SA | 65.48M |
| Biodexa Pharmaceuticals PLC | -3.094M |
| NuCana PLC | -11.17M |
| TC BioPharm (Holdings) PLC | -0.7829M |
| Moderna Inc | 9.349B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 217.87M |
| Revenue (Quarterly) | 1.369B |
| Total Expenses (Quarterly) | 1.357B |
| EPS Diluted (Quarterly) | 0.8908 |
| Gross Profit Margin (Quarterly) | 85.63% |
| Profit Margin (Quarterly) | 15.91% |
| Earnings Yield | -2.05% |
| Normalized Earnings Yield | -2.045 |